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ABSTRACT In chicken embryo erythroid cells, newly synthesized vimentin first enters a Triton X-1 00 
(TX-100)-soluble pool and subsequently assembles posttranslationally into TX-1 00-insoluble vimentin 
filaments (Blikstad 1., and E. Lazarides, ]. Cell Bioi., 96:1803-1808). Here we show that incubation of 
chicken embryo erythroid cells in a medium in which arginine has been substituted by its amino 
acid analogue, canavanine, results in the inhibition of the posttranslational assembly of vimentin into 
the TX-100-insoluble filaments. lmmunoprecipitation and subsequent SDS gel electrophoresis 
showed that the synthesis of canavanine-vimentin is not inhibited and that it accumulates in the TX-
100-soluble compartment. Pulse-chase experiments with [35S]methionine demonstrated that while 
arginine-vimentin can be rapidly chased from the soluble to the cytoskeletal fraction, canavanine-
vimentin remains in the soluble fraction, where it turns over. The effect of canavanine on the 
assembly of vimentin did not prevent the assembly of arginine-vimentin, as cells labeled with [355]-
methionine first in the presence of canavanine and then in the presence of arginine contained 
labeled canavanine-vimentin only in the soluble fraction, and arginine-vimentin in both the soluble 
and cytoskeletal fractions. These results suggest that arginine residues play an essential role in the 
assembly of vimentin in vivo. 
While the subunit composition of the five classes of interme-
diate filaments may differ in various tissues and during the 
differentiation of a particular cell type, all intermediate fila-
ments have certain common properties (reviewed in reference 
17). Intermediate filaments display a diameter of -10 nm, 
an axial periodicity of 21 nm ( 12, 18), and contain a-helical 
regions (e.g., reference 7). Recent amino acid sequence data 
have demonstrated that several intermediate filament proteins 
contain sequence homologies in a rod-like domain of a-helical 
regions, and extensive variability in the non-a-helical domains 
at the amino-termini and carboxy-termini (8). The homolo-
gies evident in the rod-like domains are likely due to require-
ments for the formation of a double coiled-coil structure (8). 
Since protofilaments from the intermediate filament subunit 
desmin may form 10 nm filaments under physiological ionic 
conditions whereas a major 38,000 M, rod-like domain lack-
ing the termini of the protein does not (7), one or both 
terminal domains may be required for filament formation. 
Subsequent work has specifically implicated the amino-ter-
minal "headpiece" domains of both desmin and vimentin as 
being required for the assembly of these two proteins into 10-
nm filaments, since vimentin and desmin modified by limited 
proteolysis of their amino termini do not form filaments in 
vitro ( 19). The molecular basis for the role of the amino-
terminal headpiece of desmin and vimentin in filament for-
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mation is unknown. It is interesting, however, that the 7,500 
M, headpiece domain of chicken desmin is very basic and 
contains 10 arginine residues (7, 8). 
Although these and additional (21, 22) studies are contrib-
uting to an understanding of the assembly of intermediate 
filaments in vitro, very little is known about the regulation of 
the assembly of these filaments in vivo. Recently we have 
investigated the formation of vimentin filaments in vivo in 
chicken embryo erythroid cells by labeling the cells with 
[ 35S)methionine, separating them into Triton X-100 soluble 
and insoluble fractions, and then subjecting these fractions to 
two-dimensional gel electrophoresis to identify vimentin (2). 
The validity of this approach was based on the demonstration 
that at steady state, virtually all of the vimentin is present in 
the cytoskeleton (2). Analyzing the distribution of labeled 
vimentin in the soluble and cytoskeletal fractions demon-
strated that newly synthesized vimentin first appears in a 
Triton X-100-soluble precursor pool before being assembled 
post-translationally into the cytoskeleton (2). 
The demonstration that the arginine-rich amino-terminal 
domain of desmin is important for filament formation in 
vitro ( 19) raises the question of whether there is a specific 
requirement for arginine in filament formation. In the current 
study we describe the effects of several amino acid analogues 













in chicken embryo erythroid cells. We found that canavanine, 
an arginine analogue, specifically blocks the assembly of newly 
synthesized vimentin into the cytoskeleton, whereas two other 
amino acid analogues do not. The unassembled vimentin 
accumulates in a Triton X-100-soluble pool, where it turns 
over. These results suggest that arginine residues play an 
essential role in the assembly of vimentin from a soluble 
precursor to insoluble intermediate filaments in vivo. Re-
placement of arginine with canavanine thus provides the first 
method for blocking the in vivo assembly of an intermediate 
filament protein. 
MATERIALS AND METHODS 
Preparation and Labeling of Cells: Erythroid cells were obtained 
by removing 11-12-d-old chicken embryos from all extra-embryonic mem-
branes, bleeding the isolated embryos in Earles balanced salt solution, and 
filtering the cells through cheesecloth (2). The cells were then collected in a 
clinical centrifuge at 500 g for 2 min ( 4•q, and washed four times by suspension 
in minimal essential media (o·q containing 0.3 ~tM methionine, and depleted 
in either arginine, threonine, or isoleucine, followed by repelleting and removing 
any buffy coat. Washed cells were resuspended in I 00 vol of minimal essential 
medium containing 0.3 ~tM methionine, 5% (volfvol) dialyzed fetal bovine 
serum that had been filtered through a 0.45-~tM pore size nitrocellulose filter, 
and 20 mM triethanolamine (pH 7.4 ). Amino acid analogues (Sigma Chemical 
Co., St. Louis, MO) were substituted at the following final concentrations (13): 
canavanine (0.2 mgfml) was substituted for arginine, ,8-hydroxynorvaline (I 
mgfml) for threonine, and o-methylthreonine (I mg/ml) for isoleucine. 
Erythroid cells were incubated in the presence of amino acid analogues for 
2-3 h (35•C) prior to labeling, with constant gentle inversion, and were then 
collected in a clinical centrifuge. For the short-term continuous labeling exper-
iments in Figs. I, 2, 3, 5 and 6, cells were resuspended to a final concentration 
of 10% (vol/vol) in fresh minimal essential medium containing 5% fetal bovine 
serum, triethanolamine, an amino acid analogue, and no unlabeled methionine. 
After 10 min at 35"C, ["S]methionine (1,200-1,400 Ci/mmol, 13.5 mCi/ml; 
Amersham Corp., Arlington Heights, IL) was added to a final concentration of 
700 ~tCi/ml. For the long-term continuous labeling experiment in Fig. 4, cells 
were preincubated as above, washed, and resuspended to a concentration of 
I% (volfvol) in fresh minimal essential medium containing 5% fetal bovine 
serum, triethanolamine, an amino acid analogue, and 0.3 ~tM unlabeled me-
thionine. Emetine was then added to an aliquot of the control cells to a 
concentration of 0.5 ~tM. After 10 min at 35•c, ["S]methionine was added to 
220 ~tCi/ml. For the pulse-chase experiment in Fig. 4, erythroid cells were 
treated as above, but after 10 min of labeling with ["S]methionine, unlabeled 
methionine was added to a concentration of0.24 mM. 
Preparation of Soluble and Cytoskeletal Fractions: At inter-
vals during the 1.5-6 h incubation, aliquots of the cell suspensions containing 
0.5-1.0 x 108 cells (10-20-~tl packed volume) were withdrawn and diluted into 
15-60 vol of 155 mM choline chloride, 5 mM HEPES, pH 7.4 at o·c, and 
collected in a clinical centrifuge. The supernatant was removed by aspiration 
and the cells lysed for 2.5 min by suspension in 10 vol oflysis buffer (I 00 mM 
KCI, 300 mM sucrose, 20 mM PIPES, I mM MgOAc, 5 mM EGTA, 0.5% 
(wt/vol) Triton X-100, pH 6.8 at 4•q. After transfer of the cell lysate to 1.5-
ml conical centrifuge tubes, the cytoskeletons were pelleted at 12,500 g for 5 
min (2o•q in an Eppendorf microcentrifuge. The supernatant was carefully 
removed and transferred to a new centrifuge tube, the detergent insoluble pellet 
was resuspended in lysis buffer to the same volume as the supernatant, and ,8-
mercaptoethanol and crystalline urea were added to each fraction (2). 
lmmunoprecipitation and Gel Electrophoresis: Antibodies 
raised against embryonic chicken skeletal muscle vimentin have been described 
(10). Aliquots (40 ~tl) of the soluble and cytoskeletal fractions were diluted 10-
fold with immunoprecipitation buffer B (3), mixed with l~tl of antiserum, and 
further processed for immunoprecipitation using method B (3). Immunopre-
cipitated polypeptides were applied to SDS/10% polyacrylamide slab gels (15). 
Following impregnation with Enhance or Enlightning (New England Nuclear, 
Boston, MA), gels were dried and exposed to Kodak X-OMA T XAR-5 X-ray 
film at -so·c. The film was preflashed to an absorbance of about 0.15 at 540 
nm ( 16), and exposed within the range of linear response. Fluorographs were 
scanned with a densitometer (E. C. Corporation, Fort Lauderdale, FL) and the 
vimentin peaks were integrated by computer. 
Estimation of 35S Incorporation and Total Protein Concen-
tration: After solubilization of the cytoskeletons in urea, 2-~tl aliquots of 
the soluble and cytoskeletal fractions were decolorized, tRNA was hydrolyzed, 
1310 RAPID COMMUNICATIONS 
and the samples were assayed for trichloracetic acid-insoluble "S (20). Total 
incorporation of "S was determined by summation of the radioactivity in the 
soluble and cytoskeletal fractions. The concentration of total protein in the 
soluble and cytoskeletal fractions was estimated according to Bradford ( 4) using 
BSA as the standard. 
RESULTS 
Partitioning of Newly Synthesized Vimentin into 
Soluble and Cytoskeletal Compartments 
Chicken embryo erythroid cells preincubated for 3 h with 
analogues for either arginine, threonine, or isoleucine incor-
porated [35S]methionine into total protein at rates 50-I 00% 
that of controls (Fig. l A), which facilitates the comparison of 
the synthesis of specific polypeptides (Fig. I B). Many of the 
Triton X-1 00-soluble polypeptides synthesized in the presence 
of canavanine had relative mobilities in SDS/polyacrylamide 
gels similar to those of control polypeptides, although some 
differences in the total pattern of polypeptides were evident 
(Fig. l B, lanes 1 and 3). The most striking effect of canavan-
ine was that the cytoskeletal fraction of cells incubated with 
this amino acid analogue did not contain a newly synthesized 
polypeptide corresponding to vimentin, even though two 
other major erythrocyte cytoskeletal polypeptides, a- and 
{3-spectrin, were incorporated into the cytoskeletons of 
both control- and canavanine-treated cells (Fig. l B, lanes 2 
and 4). As previously noted for other proteins containing 
canavanine ( 13), the canavanine-spectrin bands were more 
diffuse than in controls, and had a slower relative mobility. 
Since spectrin was incorporated into the cytoskeletal fraction, 
canavanine did not inhibit nonspecifically the assembly of all 
cytoskeletal proteins. 
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FIGURE 1 Effects of amino acid analogues on protein synthesis. (A) 
Erythroid cells from 11-12-d-old chicken embryos were preincu-
bated for 3 h in an amino acid analogue, then labeled continuously 
with [35S]methionine for the indicated incubation times in the 
presence of the analogues. The incorporation of [35S]methionine 
into protein is normalized to total protein. e, control cells; 0, 
canavanine-treated cells; .&, 13-hydroxynorvaline; •, a-methyl-
threonine-treated cells. (8) [35S]methionine-labeled polypeptides in 
the soluble (lanes 1 and 3) and cytoskeletal (lanes 2 and 4) fractions 
of erythroid cells incubated in arginine (lanes 1 and 2) or canavanine 
(lanes 3 and 4). For clarity, lane 1 is from cells labeled for 30 min, 
and all other lanes are from cells labeled for 3 h. Vimentin is 
designated by v, the spectrin subunits by a and /3, and canavanine-
spectrin subunits by a small black dot. 
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Vimentin could not be identified readily in the soluble 
fractions of either control- or canavanine-treated cells (Fig. 
I B). To identify vimentin in the soluble fraction and to 
determine the distribution of canavanine-vimentin in the 
Triton X-100-soluble and insoluble fractions, we used im-
munoprecipitation with a vimentin-specific antiserum. As 
shown in Fig. 2A and quantified in Fig. 3A, control erythroid 
cells incubated in medium supplemented with arginine con-
tained newly synthesized vimentin in both the soluble and 
cytoskeletal fractions. In agreement with previous work (2), 
the amount of labeled vimentin in the soluble pool quickly 
reached a plateau (45 min), while the amount of labeled 
vimentin in the cytoskeletal fraction exhibited a lag, but then 
increased in an approximately linear fashion. Within 60-90 
min, the amount of labeled vimentin in the cytoskeletal 
fraction exceeded the amount in the soluble fraction. Similar 
to controls, cells incubated with {3-hydroxynorvaline (Figs. 
2 C and 3 C) or o-methylthreonine (Figs. 2 D and 3D), dis-
played a saturation of the soluble pool, and a greater amount 
of newly synthesized vimentin in the cytoskeletal compared 
with the soluble fraction by 90 min of labeling. The amount 
of labeled vimentin in the cytoskeletal fraction exceeded the 
amount in the soluble fraction by 60 min for cells incubated 
in arginine (Fig. 3A) or o-methylthreonine (Fig. 3D), and by 
90 min for those incubated in {3-hydroxynorvaline (Fig. 3 C). 
This suggests that {3-hydroxynorvaline may have a subtle effect 
on vimentin assembly. 
Cells incubated with canavanine also synthesized vimentin, 
and at a rate similar to controls (Fig. 3, A and B). However, 
canavanine has two effects on newly synthesized vimentin 
which are consistent with our inability to identify it in cell 
extracts (Fig. 1 B). First, canavanine-vimentin, unlike vimen-
tin synthesized with arginine or in the presence of the other 
two analogues, consistently migrated on SDS/polyacrylamide 
gels as a diffuse band with a slower relative mobility than 
arginine-vimentin (Fig. 2B). This is similar to what was 
observed with a- and {3-spectrin (Fig. 1 B) and to what has 
been previously found for actin and other proteins synthesized 
in the presence of canavanine ( 13 ). Second, the kinetic behav-
ior of newly synthesized canavanine-vimentin differed mark-
edly from arginine-vimentin, or vimentin synthesized in the 
presence of threonine or isoleucine analogues. The amount 
of newly synthesized canavanine-vimentin in the soluble frac-
tion did not reach a plateau during a 90-min labeling period, 
and even after 90 min the amount of labeled vi men tin in the 
soluble fraction exceeded the amount of labeled canavanine-
vimentin in the cytoskeletal fraction by about fourfold. The 
absolute amount of newly synthesized canavanine-vimentin 
in the soluble fraction was more than twofold greater than 
the soluble pool of arginine-vimentin in control cells suggest-
ing that canavanine-vimentin accumulated in the soluble 
fraction. Thus canavanine specifically interfered with the 
cytoskeletal assembly of vi men tin. 
Soluble Arginine-Vimentin, but not Canavanine-
Vimentin, Serves as Precursor to 
Cytoskeletal Vimentin 
We next designed a pulse-chase experiment to compare the 
post-translational behavior of canavanine-vimentin versus ar-
ginine-vimentin in the soluble fraction. We labeled cells 
briefly with (35S)methionine, then chased the labeled methi-
onine with an excess of unlabeled methionine, thus fixing the 
number of labeled vimentin polypeptides early in the chase 
period. The results for the control cells confirmed a previous 
study (2) showing that arginine-vimentin is initially parti-
tioned primarily in the soluble fraction (Fig. 4£). The amount 
of labeled vimentin in the soluble fraction then decreased 
rapidly while the amount of labeled vimentin in the cytoskel-
etal fraction increased proportionally (Fig. 4£). This relation-
ship indicated that the soluble arginine-vimentin serves as a 
precursor for the cytoskeletal vimentin (2). A strikingly dif-
ferent result was obtained with pulse-labeled canavanine-
vimentin (Fig. 4 F). First, most of the labeled canavanine-
vimentin remained in the soluble fraction throughout the 6-
h chase period, which conclusively demonstrated that very 
little canavanine-vimentin is assembled into the cytoskeleton. 
Second, although there was no evident turnover of arginine-
vimentin during the 6-h time period (Fig. 4 E), -50% of the 
canavanine-vimentin turned over during the chase period 
(Fig. 4 F). This difference in vimentin stability may reflect the 
previously reported increased rates of degradation of proteins 
that .contain canavanine (9, 14 ). Alternatively, the cytoskeletal 
localization of arginine-vimentin as compared with the solu-
ble nature of canavanine-vimentin may itself lead to differ-
ential turnover. 





FIGURE 2 Effect of amino acid analogues on 
vimentin assembly. Cells from the experiment in 
Fig. 1 were labeled with [35S]methionine and 
separated into Triton X-100-soluble (lanes 1-5) 
and insoluole (lanes 6-10) fractions and proc-
essed for immunoprecipitation of vimentin, elec-
III!!!J·,.~·v trophoresis, and fluorography as in Materials and 
Methods. The fluorograph depicts vimentin in 
the soluble and cytoskeletal fractions at the fol-
lowing times: lanes 1 and 6, 15 min labeling; 
lanes 2 and 7, 30 min labeling; lanes 3 and 8, 45 
min labeling; lanes 4 and 9, 60 min labeling; lanes 
5 and 10, 90 min labeling. (A) control cells, with 
vimentin designated v; (8) cells incubated with 
canavanine, with vimentin designated c-v; (C) 
the vimentin region of the gel of cells incubated 
with I'J-hydroxynorvaline; (D) the vimentin region 
of the gel of cells incubated with o-methylthreonine. A and 8 were processed for immunoprecipitation at the same time, and the 
fluorographs exposed 7 h. C and D were processed simultaneously at a later date and the fluorographs exposed 9 h. 
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FIGURE 3 Quantification of the effect of amino acid analogues on 
vimentin assembly. Fluorographs from the gels used for Fig. 2, but 
somewhat less exposed, were scanned and the vimentin peak area 
integrated as in Materials and Methods to display the amount of 
newly synthesized vimentin in the soluble (0) and cytoskeletal (e) 
fractions of cells incubated as controls (A) or with canavanine (8), 
{J-hydroxynorvaline (C) or o-methylthreonine (D). A and 8 can be 
compared quantitatively with each other, as can C and D, but 
comparisons between the two groups are qualitative since they 
were not processed simultaneously for immunoprecipitation and 
hence there may be slight variations in vimentin recovery. 
The pulse-chase experiment necessarily entailed several par-
allel control experiments with continuous labeling of cells, to 
demonstrate the viability of the cells throughout the pulse-
chase period, and to demonstrate that long-term continuous 
labeling supported the conclusions derived from Fig. 3. As 
shown in Fig. 4A, cells preincubated with arginine or cana-
vanine for 2 h, then labeled continuously, incorporated in-
creasing amounts of (35S]methionine over a 6-h period, which 
establishes the viability of the cells during the period of the 
pulse-chase. The rate of incorporation did, however, decline 
somewhat after 2 h of labeling. The cells treated with cana-
vanine incorporated ~50% as much P5S]methionine as con-
trols, which is less than in Fig. I, but consistent with previous 
reports (6, 13). 
To determine if the rate of incorporation of vimentin into 
the cytoskeleton was similar to the rate of protein synthesis 
during the 6-h culture, vimentin was recovered by immuno-
precipitation from the soluble and cytoskeletal fractions of 
cells incubated with either arginine or canavanine and labeled 
continuously with (35S]methionine. In control cells the soluble 
pool of vimentin reached a plateau value within 1 h, while 
the amount of labeled vimentin in the cytoskeletal fraction 
increased throughout the labeling period (Fig. 4 C) thus indi-
cating continuous vimentin assembly. Significantly, very little 
vi men tin accumulated in the cytoskeletal fraction of canavan-
ine-treated cells even upon long-term culture, while the 
amount of labeled vimentin in the soluble fraction continued 
to increase (Fig. 4 D). The rate of accumulation of canavanine-
vimentin in the soluble pool declined somewhat after 2 h of 
labeling (Fig. 4D), but this may in part reflect altered cellular 
metabolism upon prolonged culture, as the soluble vimentin 
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in the control cells declined during this same period (Fig. 
4 C). As in Fig .. 3, the absolute level of labeled vimentin in 
the soluble pool was higher in canavanine- than in arginine-
treated cells (Fig. 4, C and D), although precise quantification 
was not feasible. Since canavanine-vimentin was found almost 
exclusively in the soluble fraction, this further supports the 
existence of a soluble precursor pool of vimentin (2), and in 
conjunction with pulse-chase experiments (reference 2, and 
above), eliminates the possibility that the soluble pool arises 
by dissociation of vimentin from filaments during cell lysis. 
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FIGURE 4 Canavanine inhibition of vimentin assembly and vimen-
tin turnover in the soluble fraction. Chicken embryo erythroid cells 
were preincubated in minimal essential medium containing arginine 
or canavanine, then labeled with [l5S]methionine in the presence 
of canavanine or arginine, with or without emetine. Cells were 
separated into soluble or cytoskeletal fractions, and vimentin quan-
tified by immunoprecipitation and fluorography as in Materials and 
Methods. (A) Incorporation of [35S]methionine into total protein in 
the presence of arginine (e), canavanine (0), or arginine and 0.5 
ILM emetine (.&); (8-D) distribution of labeled vimentin between 
the soluble (0) and cytoskeletal (e) fractions of cells labeled contin-
uously in the presence of arginine and emetine (8), arginine (C), or 
canavanine (D); (E and f) distribution of labeled vimentin between 
the soluble and cytoskeletal fractions of cells labeled with [355]-
methionine for 10 min, then chased with unlabeled methionine, in 
the presence of arginine (E) or canavanine (f). The amount of total 
labeled vimentin is indicated (X). Fluorographs were exposed for 
75 h (8), 13 h (C-E), and 37 h (f). 
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As noted above, cells incubated in canavanine during long-
term culture had lower rates of protein synthesis than control 
cells (Fig. 4A). The lower rate of protein synthesis in cells 
incubated in canavanine cannot itselflead to the preferential 
partitioning of newly synthesized vimentin into the soluble 
fraction. This conclusion is based on data showing that cells 
incubated in 0.5 ~m emetine, an inhibitor of ribosome elon-
gation, had lower rates of protein synthesis than either control 
cells or cells incubated in canavanine (Fig. 4A), and yet the 
partitioning and kinetic behavior of newly synthesized vimen-
tin resembled that in controls (Fig. 4B). It is, however, inter-
esting to note that the soluble pool ofvimentin saturated after 
1 h in control cells, but not for 2 h in emetine-treated cells 
(Fig. 4, B and C). 
Centrifugation of Soluble Vimentin 
Triton X-100-soluble fractions from cells incubated with 
arginine or canavanine, and labeled with [35S]methionine, 
were centrifuged for up to 1 h at 150,000 g in an air-driven 
microcentrifuge to determine if soluble canavanine- and ar-
ginine-vimentin displayed similar sedimentation properties. 
Immunoprecipitation of vimentin from the supernatant (lanes 
1, 3, 5, and 7) and pellet (lanes 2, 4, 6, and 8) demonstrated 
that both canavanine- and arginine-vimentin remained exclu-
sively in the supernatant (Fig. 5). As previously discussed for 
arginine-vimentin (2}, these data argue against the possibility 
that the soluble vimentin represents large filaments that are 
soluble in Triton X-100. These data, however, do not rule 
out the possibility that soluble vimentin forms protofilaments 
consisting of a small number of subunits (8). 
Arginine Reverses the Canavanine Block to 
Vimentin Assembly 
If canavanine blocks the assembly of vimentin into the 
cytoskeletal fraction due to its incorporation into and altera-
tion of the charge and conformation of vimentin, then the 
effect of canavanine on erythroid cells should be reversible. 
To test this hypothesis, we preincubated cells in arginine or 
canavanine prior to a 1-h labeling with (35S]methionine. The 
results show that about half of the arginine-vimentin (Fig. 6, 
lanes 1 and 2), but no detectable canavanine-vimentin (Fig. 
6, lanes 3 and 4) was present in the cytoskeleton. One half of 
the cells in canavanine were then washed and labeled with 
( 35S]methionine in the presence of arginine. Vimentin in cells 
labeled continuously in canavanine remained primarily in the 
soluble fraction (Fig. 6, lanes 5 and 6), whereas cells labeled 
in canavanine and then arginine yielded a different distribu-
tion of vimentin. About half of the arginine-vimentin, which 
migrated as a discrete band, was present in the cytoskeletal 
fraction (Fig. 6, lane 8), and about half was present in the 
soluble fraction (lane 7), similar to cells labeled continuously 
in arginine (lanes 1 and 2). Virtually all of the canavanine-
vimentin was present in the soluble fraction as a diffuse band 
with a slower relative mobility than the discrete band of 
arginine-vimentin (Fig. 6, lane 7), and no canavanine-vimen-
tin was detectable in the cytoskeletal fraction (lane 8). We 
interpret these data to indicate that the diffuse band of soluble 
vimentin represents canavanine-vimentin that cannot form 
filaments. The discrete bands of vimentin in both the soluble 
and cytoskeletal fractions represent arginine-vimentin which, 
as shown in Figs. 2, 3, and 4, and reference 2, enters into a 




FIGURE 5 High speed centrifugation of soluble vimentin. Aliquots 
of 50 ~I of the Triton X-100-soluble fractions of cells labeled with 
[ 35S]methionine for 1 h in the presence of arginine (lanes 1, 2, 4, 
and 5) or canavanine (lanes 3, 4, 7, and 8) were centrifuged in a 
Beckman airfuge at 150,000 g for 30 min (lanes 7-4) or 60 min 
(lanes 5-8) as previously described (2). The pellet was solubilized 
and suspended to the same volume as the supernatant, and argi-
nine-vimentin (v) and canavanine - vimentin (c-v) recovered from 
the supernatant (lanes 1, 3, 5, and 7) and pellets (lanes 2, 4, 6, and 
8) by immunoprecipitation. 
We conclude that the incorporation of canavanine into vi-
mentin irreversibly prevents the assembly of canavanine-
vimentin, while treatment of erythroid cells with canavanine 
does not interfere with the assembly of arginine-vimentin. 
This conclusion thus argues against an indirect effect of 
canavanine on vimentin assembly, such as may occur in 
response to induction of the heat shock response by canavan-
ine ( 13). Finally, it is interesting to note that the small amount 
of canavanine-vimentin that is incorporated into the cyto-
skeleton (Fig. 6, lane 6) has a more rapid electrophoretic 
mobility than the soluble canavanine-vimentin (lane 5). The 
increased mobility of this vimentin may be due to the incor-
poration of lesser amounts of canavanine, and hence this 
vimentin is more competent to assemble. 
DISCUSSION 
We have used the arginine analogue, canavanine, to demon-
strate for the first time a means for blocking the in vivo 
assembly of vimentin, the major intermediate filament pro-
tein in avian erythroid cells ( 11 ). Substitution of other amino 
acid analogues such as {3-hydroxynorvaline for threonine, or 
o-methylthreonine for isoleucine did not block vimentin as-
sembly in chicken embryo erythroid cells, suggesting that 
arginine residues are important for the assembly of vimentin. 
That canavanine does not nonspecifically prevent the assem-
bly of cytoskeletal polypeptides is evident since a- and {3-
spectrin still assemble into the cytoskeleton in the presence of 
canavanine. 
Our demonstration of the potential significance of arginine 
residues for the assembly of vimentin is compatible with two 
related yet independent lines of research from other labora-
tories. Geisler and co-workers (7) have demonstrated that 
there are 10 arginine residues in the positively-charged, 73 
residue non-a-helical headpiece of chicken desmin, which has 
a very similar amino acid sequence to vimentin. Second, 
Nelson and Traub ( 19) have demonstrated that the headpiece 
of both vimentin and desmin is required for formation of 10-
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FIGURE 6 Arginine reverses the canavanine block to vimentin as-
sembly. Erythroid cells were preincubated for 2 h in minimal 
essential medium containing arginine (lanes 1 and 2) or canavanine 
(lanes 3 and 4) prior to a 1 h continuous labeling with [35S)methio-
nine in the presence of arginine (lanes 1 and 2) or canavanine (lanes 
3 and 4). At this time, aliquots of cells were separated into soluble 
(lanes 1 and 3) or cytoskeletal (lanes 2 and 4) fractions. One half of 
the remaining cells in canavanine were washed once by centrifu-
gation in min.imal essential medium containing 0.4 mM arginine, 
then suspended in minimal essential medium containing arginine 
and [35S]methionine. The erythroid cells were incubated for an 
additional 1 .5 h, at which time the cells labeled continuously in the 
presence of canavanine (lanes 5 and 6), or in canavanine then 
arginine (lanes 7 and 8), were separated into soluble (lanes 5 and 
7) and cytoskeletal (lanes 6 and 8) fractions. Arginine-vimentin (v) 
and canavanine- vimentin (c-v) were immunoprecipitated from the 
fractions and subjected to gel electrophoresis, then fluorography 
for 60 h. 
nm filaments in vitro. Therefore, substitution of canavanine 
in the headpiece of vimentin may sufficiently alter its distri-
bution of charges or its conformation to prevent filament 
assembly. Since the head region of desmin also contains ten 
threonine residues (8), it is interesting to note that substitution 
with /3-hydroxynorvaline did not prevent the assembly of 
vimentin into the cytoskeleton, although it did slightly retard 
this process. It is also possible that the disruptive effect that 
canavanine has on filament formation is due to changes in 
the charge or conformation of a rod domain in vimentin 
which may be homologous to the 38,000 M, rod domain of 
desmin (7, 8). In desmin, the 38,000 M, rod domain contains 
a substantial number of arginine residues and has been pos-
tulated to be involved in protofilament formation (8). 
Atlhough our data are consistent with the above hypothesis 
on the role of arginine in filament formation, it is not yet 
possible to determine the exact mechanism by which cana-
vanine blocks vimentin assembly in vivo. 
In many cells, the level of tubulin mRNA (5), and hence 
tubulin synthesis (I) decreases rapidly in response to increases 
in the monomer pool. Since vimentin synthesis did not spe-
cifically decline upon canavanine-treatment, which may 
slightly increase the size of the soluble vimentin pool, it is 
possible that the regulation of vimentin synthesis differs from 
1314 RAPID CoMMUNICATIONS 
tubulin synthesis. However, the decreased level of tubulin 
mRNA occurred in response to the depolymerization of ex-
isting microtubules, so the change in the size of the soluble 
pool was very large. To determine whether the soluble pool 
ofvimentin indeed affects vimentin synthesis may, therefore, 
require larger charges in soluble pool size than occurred in 
the present study. 
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